These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5332873)

  • 21. Effectiveness of cell walls of Mycobacterium bovis strain BCG administered by various routes and in different adjuvants in protecting mice against airborne infection with Mycobacterium tuberculosis strain H37Rv.
    Anacker RL; Barclay WR; Brehmer W; Goode G; List RH; Ribi E; Tarmina DF
    Am Rev Respir Dis; 1969 Feb; 99(2):242-8. PubMed ID: 4975012
    [No Abstract]   [Full Text] [Related]  

  • 22. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
    Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
    Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis.
    Aldwell FE; Brandt L; Fitzpatrick C; Orme IM
    Infect Immun; 2005 Mar; 73(3):1903-5. PubMed ID: 15731098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
    Williams A; Hatch GJ; Clark SO; Gooch KE; Hatch KA; Hall GA; Huygen K; Ottenhoff TH; Franken KL; Andersen P; Doherty TM; Kaufmann SH; Grode L; Seiler P; Martin C; Gicquel B; Cole ST; Brodin P; Pym AS; Dalemans W; Cohen J; Lobet Y; Goonetilleke N; McShane H; Hill A; Parish T; Smith D; Stoker NG; Lowrie DB; Källenius G; Svenson S; Pawlowski A; Blake K; Marsh PD
    Tuberculosis (Edinb); 2005; 85(1-2):29-38. PubMed ID: 15687025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
    Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunisation of red mice against tuberculosis by vaccination with killed vaccines. I. Comparison of living BCG with various killed vaccines administered in aqueous and liquid paraffin suspensions.
    JESPERSEN A; MAGNUSSON M
    Acta Pathol Microbiol Scand; 1956; 39(6):431-45. PubMed ID: 13381491
    [No Abstract]   [Full Text] [Related]  

  • 28. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.
    Skinner MA; Buddle BM; Wedlock DN; Keen D; de Lisle GW; Tascon RE; Ferraz JC; Lowrie DB; Cockle PJ; Vordermeier HM; Hewinson RG
    Infect Immun; 2003 Sep; 71(9):4901-7. PubMed ID: 12933831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.
    Nuermberger EL; Yoshimatsu T; Tyagi S; Bishai WR; Grosset JH
    Infect Immun; 2004 Feb; 72(2):1065-71. PubMed ID: 14742554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep.
    Balseiro A; Altuzarra R; Vidal E; Moll X; Espada Y; Sevilla IA; Domingo M; Garrido JM; Juste RA; Prieto M; Pérez de Val B
    PLoS One; 2017; 12(7):e0180546. PubMed ID: 28678885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The immunological responses induced by Mycobacterium tuberculosis heat shock protein 16.3 and its synthetic peptide in mice].
    Shi CH; Zhang TF; Zhu DS; Zhang H; Bai B; Zhao Y; Yue CL; Zhao L; Liu JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):603-7. PubMed ID: 19958680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.
    Yarkoni E; Rapp HJ
    Infect Immun; 1980 Jun; 28(3):881-6. PubMed ID: 6995325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new attenuated Mycobacterium bovis vaccine protects brushtail possums (Trichosurus vulpecula) against experimental tuberculosis infection.
    Collins DM; de Lisle GW; Aldwell FE; Buddle BM
    Vaccine; 2007 Jun; 25(24):4659-64. PubMed ID: 17498852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
    Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
    Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of immunities against tuberculosis between the guinea pigs treated with dead tubercle bacilli paraffin-oil vaccine and those treated with BCG, by the method of slide cell culture.
    YAMADA S
    Sci Rep Res Inst Tohoku Univ Med; 1952 Mar; 3(3):333-48. PubMed ID: 14958412
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunization of rabbits with viable BCG and nonliving cell wall vaccines.
    Larson CL; Baker RE; Baker MB
    Am Rev Respir Dis; 1968 Dec; 98(6):944-53. PubMed ID: 4881317
    [No Abstract]   [Full Text] [Related]  

  • 38. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of anti-tuberculous protection to lung granuloma produced by intravenous injection of synthetic 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with or without specific antigens.
    Yamamoto K; Kakinuma M; Kato K; Okuyama H; Azuma I
    Immunology; 1980 Aug; 40(4):557-64. PubMed ID: 7000685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.